Publications by authors named "Fumihito Ushiyama"

Claim this Profile
and Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.
Aiko Masuko, Iichiro Takata, Kiyoko Fujita, Hirotoshi Okumura, Fumihito Ushiyama

Antimicrob Agents Chemother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532.
Fumihito Ushiyama, Hajime Takashima, Yohei Matsuda, Yuya Ogata, Naoki Sasamoto

Bioorg Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity.
Yousuke Yamada, Hajime Takashima, David Lee Walmsley, Fumihito Ushiyama, Yohei Matsuda

J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Fumihito Ushiyama, Hideaki Amada, Yasuhiro Mihara, Tomoki Takeuchi, Nozomi Tanaka-Yamamoto

Bioorg Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation.
Fumihito Ushiyama, Hideaki Amada, Tomoki Takeuchi, Nozomi Tanaka-Yamamoto, Harumi Kanazawa

ACS Omega· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis